6QZJ
 
 | Crystal structure of human Aquaporin 7 at 2.2 A resolution | 分子名称: | Aquaporin-7, GLYCEROL, PHOSPHATE ION | 著者 | de Mare, S.W.-H, Venskutonyte, R, Eltschkner, S, Lindkvist-Petersson, K. | 登録日 | 2019-03-11 | 公開日 | 2019-11-27 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Structural Basis for Glycerol Efflux and Selectivity of Human Aquaporin 7. Structure, 28, 2020
|
|
6QZI
 
 | Crystal structure of human Aquaporin 7 at 1.9 A resolution | 分子名称: | Aquaporin-7, GLYCEROL, PHOSPHATE ION | 著者 | de Mare, S.W.-H, Venskutonyte, R, Eltschkner, S, Lindkvist-Petersson, K. | 登録日 | 2019-03-11 | 公開日 | 2019-11-27 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Structural Basis for Glycerol Efflux and Selectivity of Human Aquaporin 7. Structure, 28, 2020
|
|
8SJY
 
 | |
8C9H
 
 | AQP7_inhibitor | 分子名称: | Aquaporin-7, ethyl 4-[(4-pyrazol-1-ylphenyl)methylcarbamoylamino]benzoate | 著者 | Huang, P, Venskutonyte, R, Gourdon, P, Lindkvist-Petersson, K. | 登録日 | 2023-01-22 | 公開日 | 2024-01-31 | 最終更新日 | 2024-03-06 | 実験手法 | ELECTRON MICROSCOPY (3.2 Å) | 主引用文献 | Molecular basis for human aquaporin inhibition. Proc.Natl.Acad.Sci.USA, 121, 2024
|
|
2BRV
 
 | |
2WFI
 
 | |
2WFJ
 
 | Atomic resolution crystal structure of the PPIase domain of human cyclophilin G in complex with cyclosporin A. | 分子名称: | 1,2-ETHANEDIOL, CHLORIDE ION, CYCLOSPORIN A, ... | 著者 | Stegmann, C.M, Sheldrick, G.M, Wahl, M.C. | 登録日 | 2009-04-06 | 公開日 | 2009-06-16 | 最終更新日 | 2025-04-09 | 実験手法 | X-RAY DIFFRACTION (0.75 Å) | 主引用文献 | The Thermodynamic Influence of Trapped Water Molecules on a Protein-Ligand Interaction. Angew.Chem.Int.Ed.Engl., 48, 2009
|
|
2BRW
 
 | |
2YMK
 
 | |
2RKO
 
 | |
6OLY
 
 | |
6QAM
 
 | |
6QWR
 
 | |
5I32
 
 | Ammonia permeable aquaporin AtTIP2;1 | 分子名称: | Aquaporin TIP2-1 | 著者 | Kirscht, A, Nissen, P, Kjellbom, P, Gourdon, P, Johanson, U. | 登録日 | 2016-02-09 | 公開日 | 2016-04-06 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (1.18 Å) | 主引用文献 | Crystal Structure of an Ammonia-Permeable Aquaporin. Plos Biol., 14, 2016
|
|
5J4I
 
 | |
5J4N
 
 | |
6UFE
 
 | The structure of a potassium selective ion channel at atomic resolution | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, POTASSIUM ION, Transporter | 著者 | Langan, P.S, Vandavasi, V.G, Sullivan, B, Afonine, P.V, Weiss, K.L. | 登録日 | 2019-09-24 | 公開日 | 2020-08-05 | 最終更新日 | 2023-10-11 | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | 主引用文献 | The structure of a potassium-selective ion channel reveals a hydrophobic gate regulating ion permeation. Iucrj, 7, 2020
|
|
6V8Y
 
 | Structure of a Sodium Potassium ion Channel | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, POTASSIUM ION, Potassium channel protein, ... | 著者 | Roy, R, Weiss, K.L, Coates, L. | 登録日 | 2019-12-12 | 公開日 | 2021-04-14 | 最終更新日 | 2023-10-11 | 実験手法 | X-RAY DIFFRACTION (1.53 Å) | 主引用文献 | Structural plasticity of the selectivity filter in a nonselective ion channel. Iucrj, 8, 2021
|
|
7ER6
 
 | Crystal structure of human Biliverdin IX-beta reductase B | 分子名称: | Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, SULFATE ION | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ER9
 
 | Crystal structure of human Biliverdin IX-beta reductase B with Febuxostat (TEI) | 分子名称: | 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.45 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ERE
 
 | Crystal structure of human Biliverdin IX-beta reductase B with Pyrantel Pamoate (PPA) | 分子名称: | 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ERC
 
 | Crystal structure of human Biliverdin IX-beta reductase B with Deferasirox (ICL) | 分子名称: | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.5 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ER7
 
 | Crystal structure of hyman Biliverdin IX-beta reductase B with Tamibarotene (A80) | 分子名称: | 4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl]benzoic acid, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ERD
 
 | Crystal structure of human Biliverdin IX-beta reductase B with Flunixin Meglumin (FMG) | 分子名称: | 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|
7ER8
 
 | Crystal structure of human Biliverdin IX-beta reductase B with Sulfasalazine (SAS) | 分子名称: | 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID, Flavin reductase (NADPH), NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... | 著者 | Griesinger, C, Lee, D, Ryu, K.S, Kim, M, Ha, J.H. | 登録日 | 2021-05-06 | 公開日 | 2022-01-19 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.45 Å) | 主引用文献 | Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX beta Reductase B as a Novel Thrombocytopenia Therapeutic Target. J.Med.Chem., 65, 2022
|
|